vTv Therapeutics Inc
NASDAQ:VTVT

Watchlist Manager
vTv Therapeutics Inc Logo
vTv Therapeutics Inc
NASDAQ:VTVT
Watchlist
Price: 14.9 USD 7.12%
Market Cap: 44.8m USD
Have any thoughts about
vTv Therapeutics Inc?
Write Note

vTv Therapeutics Inc
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

vTv Therapeutics Inc
Cash Equivalents Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
vTv Therapeutics Inc
NASDAQ:VTVT
Cash Equivalents
$45.5m
CAGR 3-Years
62%
CAGR 5-Years
98%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash Equivalents
$7.3B
CAGR 3-Years
-16%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Gilead Sciences Inc
NASDAQ:GILD
Cash Equivalents
$5B
CAGR 3-Years
5%
CAGR 5-Years
-12%
CAGR 10-Years
-2%
Amgen Inc
NASDAQ:AMGN
Cash Equivalents
$9B
CAGR 3-Years
-9%
CAGR 5-Years
-5%
CAGR 10-Years
9%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash Equivalents
$6.5B
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
25%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash Equivalents
$2B
CAGR 3-Years
-16%
CAGR 5-Years
8%
CAGR 10-Years
12%

See Also

What is vTv Therapeutics Inc's Cash Equivalents?
Cash Equivalents
45.5m USD

Based on the financial report for Jun 30, 2024, vTv Therapeutics Inc's Cash Equivalents amounts to 45.5m USD.

What is vTv Therapeutics Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
98%

Over the last year, the Cash Equivalents growth was 261%. The average annual Cash Equivalents growth rates for vTv Therapeutics Inc have been 62% over the past three years , 98% over the past five years .

Back to Top